OTCMKTS:BIXT

Bioxytran News Headlines

$0.17

-0.01 (-5.56 %)

(As of 05/7/2021 12:00 AM ET)

Add

Today's Range

$0.11

▼

$0.17

50-Day Range

$0.07

▼

$0.18

52-Week Range

$0.00

▼

$0.33

Volume4,350 shs

Average Volume5,025 shs

Market Capitalization$17.13 million

P/E RatioN/A

Dividend YieldN/A

Beta-6.81

Bioxytran (OTCMKTS BIXT) News Headlines Today

Source:

Source	Headline
	Bioxytran (OTCMKTS:BIXT) Trading Up 5.9% americanbankingnews.com - May 7 at 12:30 AM
	Bioxytran (OTCMKTS:BIXT) Trading 157.1% Higher americanbankingnews.com - April 16 at 12:40 AM
	Bioxytran, Inc. (BIXT) finance.yahoo.com - November 3 at 5:55 PM
	Bioxytran Licenses Novel Viral Inhibitor for COVID-19 Patients finance.yahoo.com - September 21 at 9:18 AM
	Bioxytran to Internally Develop Novel Carbohydrate Galectin Inhibitor to Eliminate COVID-19 in Patients finance.yahoo.com - September 21 at 9:18 AM
	Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients finance.yahoo.com - September 21 at 9:18 AM
	Bioxytran Published A Surrogate Marker for ARDS and Stroke Patients finance.yahoo.com - September 21 at 9:18 AM

This page was last updated on 5/9/2021 by MarketBeat.com Staff

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.